Hydrochloric Acid → HCID 178441168, 화합물

HRID 1887592

반응식

HRID 1887592 반응식
[NH:1]1[C:9]2[C:4](=[CH:5][C:6](OC3C4C(C)N(C(OC(C)(C)C)=O)CC=4N=CN=3)=[CH:7][CH:8]=2)[CH:3]=[CH:2]1.N1([C:33]([N:35]2[CH:39]=[CH:38]N=C2)=[O:34])C=CN=C1.[C:40]([C:44]1[NH:48][N:47]=C(N)C=1)([CH3:43])([CH3:42])[CH3:41].Cl.C(O)(C(F)(F)F)=O>CN(C=O)C.O.C(Cl)Cl.CCOC(C)=O>[C:40]([C:44]1[CH:38]=[C:39]([NH:35][C:33]([N:1]2[C:9]3[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=3)[CH:3]=[CH:2]2)=[O:34])[NH:47][N:48]=1)([CH3:43])([CH3:42])[CH3:41]

참가 물질

10

반응물 5

HCID 313Hydrochloric AcidHCID 6422Trifluoroacetic acidHCID 682631,1'-CarbonyldiimidazoleHCID 5227873-Amino-5-tert-butylpyrazoleHCID 59394355tert-butyl 4-(1H-indol-5-yloxy)-5-methyl-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate

생성물 1

HCID 178441168HCID 178441168, 화합물

시약·촉매·용매 4

HCID 962Water용매HCID 6228Dimethylformamide용매HCID 6344Dichloromethane용매HCID 8857Ethyl Acetate용매

실험 절차

To a solution of tert-butyl 4-(1H-indol-5-yloxy)-5-methyl-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate (150 mg, 0.409 mmol) in DMF (4 mL) at rt, di(1H-imidazol-1-yl)methanone (86 mg, 0.532 mmol) is added followed by TEA (0.34 mL, 2.46 mmol). After 3 h at room temperature 5-tert-butyl-1H-pyrazol-3-amine (342 mg, 2.46 mmol) is added and the reaction left stirring at rt for 48 h. At this point as 1N HCl solution in water (2 mL) is added and EtOAc (5 mL) is added. The layers are separated and the water layer extracted 3 times with EtOAc. The organics are dried and evaporated. DCM (4 mL) and TFA (10 mL, 130 mmol) are added at 0° C. and the reaction allowed to warm to rt over 1 h. At this point the reaction is complete. TFA/DCM is evaporated and then the product is taken up in EtOAc (100 mL). NH4OH (20 mL) is added and then water. The organics are separated and the water layer extracted with EtOAc (2 times). The organics are dried and evaporated. The crude product is added to a silica gel column (ISCO) and eluted with DCM/MeOH/NH4OH (100:0:0 to 93:6:1) to isolate 5-methyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yloxy)-indole-1-carboxylic acid (5-tert-butyl-2H-pyrazol-3-yl)-amide. MS (ESI) m/z 432.0 (M+1); 1H NMR (400 MHz, MeOD) δ ppm 8.50 (s, 1H) 8.33 (d, J=9.09 Hz, 1H) 7.89 (d, J=3.54 Hz, 1H) 7.41 (d, J=2.27 Hz, 1H) 7.10 (dd, J=8.97, 2.40 Hz, 1H) 6.71 (d, J=3.54 Hz, 1H) 6.37 (s, 1H) 4.71 (d, J=6.57 Hz, 1H) 4.10-4.22 (m, 2H) 1.60 (d, J=6.82 Hz, 3H) 1.37 (s, 9H).

후처리

  1. waitthe reaction left
  2. customThe layers are separated
  3. extractionthe water layer extracted 3 times with EtOAc
  4. customThe organics are dried
  5. customevaporated
  6. temperatureto warm to rt over 1 h
  7. customTFA/DCM is evaporated
  8. additionNH4OH (20 mL) is added
  9. customThe organics are separated
  10. extractionthe water layer extracted with EtOAc (2 times)
  11. customThe organics are dried
  12. customevaporated
  13. additionThe crude product is added to a silica gel column (ISCO)
  14. washeluted with DCM/MeOH/NH4OH (100:0:0 to 93:6:1)

출처 및 근거

ORD 기록
ord-1f44e629b1764864b1c567d1e53048e2
출처 데이터셋
uspto-grants-2013_08
특허 번호
US08501756B2

연결된 노트

불러오는 중…